Shares of Trupanion Inc (NASDAQ:TRUP) have been given a consensus rating of “Buy” by the eleven brokerages that are covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $46.29.
Several research analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research note on Tuesday, February 19th. BidaskClub raised shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday, February 9th. Finally, ValuEngine raised shares of Trupanion from a “hold” rating to a “buy” rating in a research note on Wednesday, November 21st.
Trupanion stock traded up $0.15 during midday trading on Friday, hitting $29.79. 5,279 shares of the stock were exchanged, compared to its average volume of 330,240. Trupanion has a 52 week low of $22.38 and a 52 week high of $46.70. The firm has a market capitalization of $1.02 billion, a price-to-earnings ratio of -993.00 and a beta of 1.18. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.87 and a quick ratio of 1.87.
In other Trupanion news, Director Howard E. Rubin sold 17,586 shares of Trupanion stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $29.00, for a total value of $509,994.00. Following the transaction, the director now owns 188,739 shares of the company’s stock, valued at $5,473,431. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction on Tuesday, December 18th. The stock was sold at an average price of $23.94, for a total transaction of $95,760.00. Following the completion of the sale, the insider now directly owns 1,563,421 shares in the company, valued at approximately $37,428,298.74. The disclosure for this sale can be found here. In the last ninety days, insiders sold 141,486 shares of company stock worth $4,108,344. Insiders own 20.70% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Catalyst Capital Advisors LLC bought a new stake in shares of Trupanion in the fourth quarter worth $59,000. Citigroup Inc. lifted its position in shares of Trupanion by 12,818.2% in the fourth quarter. Citigroup Inc. now owns 2,842 shares of the financial services provider’s stock worth $72,000 after purchasing an additional 2,820 shares in the last quarter. Tower Research Capital LLC TRC bought a new stake in shares of Trupanion in the third quarter worth $118,000. Great West Life Assurance Co. Can lifted its position in shares of Trupanion by 105.1% in the fourth quarter. Great West Life Assurance Co. Can now owns 3,691 shares of the financial services provider’s stock worth $91,000 after purchasing an additional 1,891 shares in the last quarter. Finally, Resources Investment Advisors Inc. bought a new stake in shares of Trupanion in the fourth quarter worth $102,000.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Article: Capital gains and your 401(k) or IRA
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.